Dose de‐escalation of alemtuzumab in matched unrelated donor haematopoietic stem cell transplantation

British Journal of Haematology 2026 Open access

Read full text
Authors: Maymoon Mohammed Madkhali, Alex Mitchell, Callum Wright, Kim Frances Pearce, Srishty Aku, Sarah Pagan, Louise Duncan, Jason Lam, Jamie Macdonald, Paul Milne, Amy Publicover, Erin Hurst
+3 more Venetia Bigley, G Hale, M. P. Collin
DOI: 10.1111/bjh.70318
Cited by: 0
References: 13

Abstract

Alemtuzumab in vivo T-cell depletion is safe and effective at a single dose of 30 mg in reduced-intensity matched unrelated donor transplants.

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation CAR-T cell therapy research T-cell and B-cell Immunology

Publication details

Journal / source
British Journal of Haematology
Volume
208
Issue
4
Pages
1477–1481
Publication date
8 January 2026
Language
EN